Description: AC Immune SA, a global leader in developing precision medicine for neurodegenerative diseases (incl. Alzheimer & Parkinson's) with cutting-edge technology platforms
Monitoring patients’ specific proteinopathies, enables well-timed selection of the most appropriate therapeutic(s).
Neurodegeneration is a slow, silent pandemic. It is a moral and economic imperative to address it. Preserving neurons and preventing disease is the most promising strategy.
Discover the technologies that generated our differentiated pipeline of diagnostic and therapeutic candidates